Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases.
about
Marfan's syndromePersonalized preventive medicine: genetics and the response to regular exercise in preventive interventionsAthletes with Implantable Cardioverter DefibrillatorsBrugada syndrome, exercise, and exercise testingSudden cardiac death in athletes.Hypertrophic cardiomyopathy and sudden cardiac deathCardiovascular magnetic resonance in Marfan syndrome.The long QT syndrome family of cardiac ion channelopathies: a HuGE review.Channelopathies: Brugada syndrome, long QT syndrome, short QT syndrome, and CPVT.Arrhythmogenic right ventricular cardiomyopathy: diagnosis and risk stratification.Catecholaminergic polymorphic ventricular tachycardia in a patient with recurrent exertional syncopeSports participation in non-compaction cardiomyopathy: a systematic review.Update on Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C).Anatomical criteria of malignancy by computed tomography angiography in patients with anomalous coronary arteries with an interarterial course.Syncope and cardiac arrest during strenuous exercise associated with a novel mutation in LQTS1.Implantable Loop Recorder Monitoring for Refining Management of Children With Inherited Arrhythmia SyndromesHypertrophic cardiomyopathy family with double-heterozygous mutations; does disease severity suggest doubleheterozygosity?The Genetic Challenges and Opportunities in Advanced Heart FailureReport of the National Heart, Lung, and Blood Institute's Working Group on obesity and other cardiovascular risk factors in congenital heart disease.Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: outflow tract obstruction, coarctation of the aorta, tetralogy of Fallot, Ebstein anomaly and Marfan's syndromeThe ubiquitin proteasome system in human cardiomyopathies and heart failure.Pre-participation screening for the prevention of sudden cardiac death in athletes.Cardiovascular prevention in a high risk sport, ice hockey: applications in wider sports physical therapy practiceManagement of hypertrophic cardiomyopathy.Exercise, heart and health.Effects of lifestyle changes and high-dose β-blocker therapy on exercise capacity in children, adolescents, and young adults with hypertrophic cardiomyopathy.Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.Familial screening and genetic counselling in hypertrophic cardiomyopathy: the Rotterdam experiencePhysical activity evaluation in Yugoslav Study of the Precursors of Atherosclerosis in School Children - YUSAD study.Association of competitive and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy: results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiomSports Participation in Genotype Positive Children With Long QT Syndrome.Cardiovascular health, part 2: sports participation in athletes with cardiovascular conditions.Evaluation of lipid profiles and the use of omega-3 essential Fatty Acid in professional football players.Molecular genetics in hypertrophic cardiomyopathy: towards individualized management of the disease.Assessing the knowledge of sudden unexpected death in the young among Canadian medical students and recent graduates: a cross-sectional studyUsing guidelines for exercise in cardiac patients.Summary statement: appropriate medical care for the secondary school-aged athlete.Clinical Characteristics and Treatment of Cardiomyopathies in Children.Physical activity in hypertrophic cardiomyopathy: prevalence of inactivity and perceived barriers.Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers.
P2860
Q24553344-6B4F70F0-9BD8-455A-91B7-5893DB9A8BB1Q27027399-21E53A6F-78B8-4A64-9037-AF5E9A8BA838Q28082005-E22F3296-88F1-4294-90DA-E7B99ED133DCQ28088779-7287E8FA-E232-491C-8A6D-CAF267670937Q30218150-E776FB0A-242A-4082-9355-E69FC06D9E51Q30433865-08DDCD8C-A45C-4863-A0F1-1A6910D7A096Q30454633-22675C71-A61B-41E6-95FE-CE3CF29D1B2BQ33153638-00DA78AB-B4A1-42A7-B7C4-CBF288B0213DQ33157573-5226F8A7-3B60-4775-80CB-33533609A56FQ33157574-020413FA-43A3-45D1-A205-8198A8B1FA54Q33161060-860FA7F1-37B0-4633-9B37-13F88AA52119Q33162542-9D80F6FD-0714-4FA3-8FC3-667BE94260D2Q33162846-5A8E77D5-B3CD-4542-86EE-C95C43E800B7Q33164850-11ACA80F-BEB0-4C53-A884-C2C7E2A03C24Q33166639-D0AA6368-563A-4D56-9C35-9A05AAA2CFDFQ33167226-3F501C1D-A696-4A29-A3A9-675C11E65B82Q33580870-39524A61-E076-49F9-9953-FF363E4150A3Q33653498-1ECA762E-8C64-4D59-8D52-57806B03D0BDQ33772178-61664707-438F-4CAC-AB4C-DC541A7168C8Q33776426-86F09897-E138-4E41-9ACC-08C33FA237EDQ33816688-7ABE8726-2874-48D6-8384-D1DB89FFFBD0Q34093021-0C1CCA0A-F5F0-4E18-89F5-5DAF06B8B35FQ34191265-5E25A156-A254-4A51-8C2D-F365B404D0A1Q34647057-A416CE3A-01C7-49A6-B21F-CAAF4E0344E7Q34811388-A360AA6F-37DE-4A5B-BCEE-8B6C64A0297DQ35544610-C1F2A000-1B07-48BE-8F55-FF8768E015CAQ35797623-DDD2EE79-0A6A-4F51-8FBF-CD850D2F892AQ35812684-9F4E2515-7C45-433A-814F-3BF4A3F08428Q35827361-2B66E21D-8A38-4F28-97D3-D33373D1FF08Q35847506-39101BF9-C5D3-491B-B7C1-E427F34869E4Q35966848-7BC6E1D3-4081-4C6D-8093-1102B9208A05Q36225404-781BF3AA-966B-4ACC-9ABB-78B424303852Q36242160-091DBC1A-A8EE-498C-9678-6B1DD28ABB21Q36344118-AEA4911B-6388-4CE9-9E0D-27E74A60C825Q36496344-90648659-A4B1-406C-B6F8-ED41C3CFB32BQ36690310-07FF1D80-237E-4136-90C5-C246EB192553Q36776336-96355BE1-9005-4BE6-BB17-B55F73F66D3FQ36886275-86142414-BFD3-4CE4-9A47-EA31BBB3BD44Q37133765-10009E48-1712-451C-8B21-5EBD49C63EFFQ37259910-0FF9CC81-62B6-4A6B-9154-DE77A13D439D
P2860
Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Recommendations for physical a ...... netic cardiovascular diseases.
@ast
Recommendations for physical a ...... netic cardiovascular diseases.
@en
Recommendations for physical a ...... netic cardiovascular diseases.
@nl
type
label
Recommendations for physical a ...... netic cardiovascular diseases.
@ast
Recommendations for physical a ...... netic cardiovascular diseases.
@en
Recommendations for physical a ...... netic cardiovascular diseases.
@nl
prefLabel
Recommendations for physical a ...... netic cardiovascular diseases.
@ast
Recommendations for physical a ...... netic cardiovascular diseases.
@en
Recommendations for physical a ...... netic cardiovascular diseases.
@nl
P2093
P50
P1433
P1476
Recommendations for physical a ...... enetic cardiovascular diseases
@en
P2093
Antonio Bayés de Luna
Antonio Pelliccia
Barbara J Deal
Barry J Maron
Bernard R Chaitman
Councils on Clinical Cardiology and Cardiovascular Disease in the Young
David H Liang
David J Driscoll
Jane E Crosson
Matthew J Mitten
P304
P356
10.1161/01.CIR.0000128363.85581.E1
P407
P577
2004-06-01T00:00:00Z